Thus, when 4-carbomethoxyl-10-epigyrosanoldie E inhibits RhoA expression, this leads to a decrease in MMP-2 and MMP-9 levels, impacting the migration and invasion of Cal-27 and Ca9-22 oral cancer cells. The gene discussed is MMP9; the disease is lip and oral cavity carcinoma.